Pfizer Shares Are Trading Higher After the Company Reported Q3 Adjusted EPS and Sales That Beat Analyst Estimates and Raised Its 2024 Guidance.
Pfizer Shares Are Trading Higher After the Company Reported Q3 Adjusted EPS and Sales That Beat Analyst Estimates and Raised Its 2024 Guidance.
輝瑞股價上漲，因公司公佈第三季度調整後每股收益和銷售額超過分析師預期，並提升2024年業績展望。
Pfizer Shares Are Trading Higher After the Company Reported Q3 Adjusted EPS and Sales That Beat Analyst Estimates and Raised Its 2024 Guidance.
輝瑞股價上漲，因公司報告的第三季度調整後每股收益和銷售額超過分析師預期，並提高了2024年的業績指引。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間